{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:51:54Z","timestamp":1791280314810,"version":"4.1.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Elevated circulating estrogen levels are associated with increased risk of breast cancer in obese postmenopausal women. Following menopause, the biosynthesis of estrogens through CYP19 (aromatase)-mediated metabolism of androgen precursors occurs primarily in adipose tissue, and the resulting estrogens are then secreted into the systemic circulation. The potential links between obesity, inflammation, and aromatase expression are unknown. In both dietary and genetic models of obesity, we observed necrotic adipocytes surrounded by macrophages forming crown-like structures (CLS) in the mammary glands and visceral fat. The presence of CLS was associated with activation of NF-\u03baB and increased levels of proinflammatory mediators (TNF-\u03b1, IL-1\u03b2, Cox-2), which were paralleled by elevated levels of aromatase expression and activity in the mammary gland and visceral fat of obese mice. Analyses of the stromal-vascular and adipocyte fractions of the mammary gland suggested that macrophage-derived proinflammatory mediators induced aromatase and estrogen-dependent gene expression (PR, pS2) in adipocytes. Saturated fatty acids, which have been linked to obesity-related inflammation, stimulated NF-\u03baB activity in macrophages leading to increased levels of TNF-\u03b1, IL-1\u03b2, and Cox-2, each of which contributed to the induction of aromatase in preadipocytes. The discovery of the obesity \u2192 inflammation \u2192 aromatase axis in the mammary gland and visceral fat and its association with CLS may provide insight into mechanisms underlying the increased risk of hormone receptor-positive breast cancer in obese postmenopausal women, the reduced efficacy of aromatase inhibitors in the treatment of breast cancer in these women, and their generally worse outcomes. The presence of CLS may be a biomarker of increased breast cancer risk or poor prognosis. Cancer Prev Res; 4(3); 329\u201346. \u00a92011 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-10-0381","type":"journal-article","created":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T06:09:41Z","timestamp":1299218981000},"page":"329-346","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":329,"title":["Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland"],"prefix":"10.1158","volume":"4","author":[{"given":"Kotha","family":"Subbaramaiah","sequence":"first","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise R.","family":"Howe","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoheng","family":"Du","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gravaghi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda K.","family":"Yantiss","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi Kathy","family":"Zhou","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria A.","family":"Blaho","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Hla","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiying","family":"Yang","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levy","family":"Kopelovich","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford A.","family":"Hudis","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Dannenberg","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Medicine, 2Cell and Developmental Biology, 3Pathology and Laboratory Medicine, and 4Public Health, Weill Cornell Medical College, New York; 5Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 6Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2011,3,3]]},"reference":[{"key":"2022060816035899700_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2022060816035899700_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2008-0016","article-title":"History of aromatase: saga of an important biological mediator and therapeutic target","volume":"30","author":"Santen","year":"2009","journal-title":"Endocr Rev"},{"key":"2022060816035899700_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1677\/erc.1.00729","article-title":"Molecular links between obesity and breast cancer","volume":"13","author":"Lorincz","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"2022060816035899700_bib4","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/en.2009-0070","article-title":"Minireview: Obesity and breast cancer: the estrogen connection","volume":"150","author":"Cleary","year":"2009","journal-title":"Endocrinology"},{"key":"2022060816035899700_bib5","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","article-title":"Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women","volume":"95","author":"Key","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2022060816035899700_bib6","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","article-title":"Obesity and cancer: the role of dysfunctional adipose tissue","volume":"18","author":"van Kruijsdijk","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816035899700_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2265.2007.02755.x","article-title":"Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity","volume":"66","author":"Wake","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022060816035899700_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.57.3.6","article-title":"Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment","volume":"57","author":"Bulun","year":"2005","journal-title":"Pharmacol Rev"},{"key":"2022060816035899700_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0960-0760(01)00131-5","article-title":"Aromatase and COX-2 expression in human breast cancers","volume":"79","author":"Brodie","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2022060816035899700_bib10","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/ijc.21562","article-title":"Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer","volume":"118","author":"Irahara","year":"2006","journal-title":"Int J Cancer"},{"key":"2022060816035899700_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1020531329686","article-title":"Aromatase and prostaglandin inter-relationships in breast adipose tissue: significance for breast cancer development","volume":"76","author":"Karuppu","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"2022060816035899700_bib12","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1158\/0008-5472.CAN-05-4076","article-title":"HER-2\/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism","volume":"66","author":"Subbaramaiah","year":"2006","journal-title":"Cancer Res"},{"key":"2022060816035899700_bib13","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1210\/endo.137.12.8940410","article-title":"Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene","volume":"137","author":"Zhao","year":"1996","journal-title":"Endocrinology"},{"key":"2022060816035899700_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0960-0760(97)80013-1","article-title":"Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture","volume":"61","author":"Zhao","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2022060816035899700_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/bcr425","article-title":"The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer","volume":"4","author":"Purohit","year":"2002","journal-title":"Breast Cancer Res"},{"key":"2022060816035899700_bib16","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1210\/me.2007-0443","article-title":"Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms","volume":"22","author":"Hardy","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2022060816035899700_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1210\/jc.2008-1389","article-title":"Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance","volume":"94","author":"Salama","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2022060816035899700_bib18","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/diabetes.54.8.2277","article-title":"Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss","volume":"54","author":"Cancello","year":"2005","journal-title":"Diabetes"},{"key":"2022060816035899700_bib19","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J Lipid Res"},{"key":"2022060816035899700_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"2022060816035899700_bib21","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1200\/JCO.2009.27.2021","article-title":"Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial","volume":"28","author":"Sestak","year":"2010","journal-title":"J Clin Oncol"},{"key":"2022060816035899700_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2891-8-11","article-title":"Differential susceptibility to obesity between male, female and ovariectomized female mice","volume":"8","author":"Hong","year":"2009","journal-title":"Nutr J"},{"key":"2022060816035899700_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-9258(18)51687-2","article-title":"Metabolism of Isolated Fat Cells. I. Effects of Hormones on Glucose Metabolism and Lipolysis","volume":"239","author":"Rodbell","year":"1964","journal-title":"J Biol Chem"},{"key":"2022060816035899700_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"2022060816035899700_bib25","first-page":"429","article-title":"Cyclooxygenase-2 is overexpressed in human cervical cancer","volume":"7","author":"Kulkarni","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2022060816035899700_bib26","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1074\/jbc.M705409200","article-title":"EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange","volume":"283","author":"Subbaramaiah","year":"2008","journal-title":"J Biol Chem"},{"key":"2022060816035899700_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jpba.2007.11.047","article-title":"Development and validation of a high-performance liquid chromatography-electrospray mass spectrometry method for the simultaneous determination of 23 eicosanoids","volume":"46","author":"Blewett","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"2022060816035899700_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.plefa.2006.07.015","article-title":"Determination of endogenous tissue inflammation profiles by LC\/MS\/MS: COX- and LOX-derived bioactive lipids","volume":"75","author":"Yang","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2022060816035899700_bib29","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1194\/jlr.M800019-JLR200","article-title":"Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice","volume":"49","author":"Murano","year":"2008","journal-title":"J Lipid Res"},{"key":"2022060816035899700_bib30","doi-asserted-by":"crossref","first-page":"35279","DOI":"10.1074\/jbc.M706762200","article-title":"A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways","volume":"282","author":"Nguyen","year":"2007","journal-title":"J Biol Chem"},{"key":"2022060816035899700_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jsbmb.2006.01.007","article-title":"Sex steroids and leptin regulate 11beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: Sex specificities","volume":"99","author":"Dieudonne","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2022060816035899700_bib32","first-page":"E72","article-title":"Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women","volume":"270","author":"Nicklas","year":"1996","journal-title":"Am J Physiol"},{"key":"2022060816035899700_bib33","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"2022060816035899700_bib34","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"2022060816035899700_bib35","first-page":"1350","article-title":"Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4","volume":"10","author":"Zhao","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2022060816035899700_bib36","doi-asserted-by":"crossref","first-page":"G361","DOI":"10.1152\/ajpgi.00348.2005","article-title":"Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha","volume":"290","author":"Otani","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022060816035899700_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1189\/jlb.0210072","article-title":"Adipose tissue macrophages: their role in adipose tissue remodeling","volume":"88","author":"Suganami","year":"2010","journal-title":"J Leukoc Biol"},{"key":"2022060816035899700_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MOL.0b013e32832fa5c4","article-title":"Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome","volume":"20","author":"Fessler","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"2022060816035899700_bib39","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1096\/fj.01-0432com","article-title":"Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways","volume":"15","author":"Hwang","year":"2001","journal-title":"FASEB J"},{"key":"2022060816035899700_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.ATV.0000251608.09329.9a","article-title":"Role of the Toll-like receptor 4\/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages","volume":"27","author":"Suganami","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022060816035899700_bib41","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/j.1460-2075.1991.tb07713.x","article-title":"Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene","volume":"10","author":"Savouret","year":"1991","journal-title":"EMBO J"},{"key":"2022060816035899700_bib42","article-title":"Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden","volume-title":"Oncogene","author":"Connelly","year":"2010"},{"key":"2022060816035899700_bib43","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1210\/en.2008-1405","article-title":"Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity","volume":"150","author":"Rogers","year":"2009","journal-title":"Endocrinology"},{"key":"2022060816035899700_bib44","doi-asserted-by":"crossref","first-page":"35983","DOI":"10.1074\/jbc.M507339200","article-title":"Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways","volume":"280","author":"D'Eon","year":"2005","journal-title":"J Biol Chem"},{"key":"2022060816035899700_bib45","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1210\/en.2008-0971","article-title":"Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice","volume":"150","author":"Riant","year":"2009","journal-title":"Endocrinology"},{"key":"2022060816035899700_bib46","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.steroids.2010.01.012","article-title":"Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future","volume":"75","author":"Blair","year":"2010","journal-title":"Steroids"},{"key":"2022060816035899700_bib47","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1158\/1055-9965.EPI-05-0106","article-title":"Body mass and mortality after breast cancer diagnosis","volume":"14","author":"Whiteman","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816035899700_bib48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10549-007-9785-3","article-title":"Is obesity an independent prognosis factor in woman breast cancer?","volume":"111","author":"Majed","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"2022060816035899700_bib49","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1586\/era.09.71","article-title":"Influence of obesity on breast cancer receptor status and prognosis","volume":"9","author":"Rose","year":"2009","journal-title":"Expert Rev Anticancer Ther"}],"updated-by":[{"DOI":"10.1158\/1940-6207.capr-22-0202","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"record-id":"37434"},{"DOI":"10.1158\/1940-6207.capr-22-0202","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000}}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/4\/3\/329\/3152160\/329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/4\/3\/329\/3152160\/329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T13:22:58Z","timestamp":1654694578000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/4\/3\/329\/49803\/Obesity-Is-Associated-with-Inflammation-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,3]]},"published-print":{"date-parts":[[2011,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-10-0381","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22524779","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22524776","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6544418.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6544418","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22524779.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22524776.v1","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}